Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATREUS Trial
2011-006330-16Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Feb 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of trabectedin in pleural mesothelioma (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Progression-free survival. Started Feb 2013; status: completed.
02
Drugs
trabectedin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2011-006330-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006330-16.